TY  - GEN
AU  - Ardizzoni,Andrea
AU  - Tiseo,Marcello
AU  - Boni,Luca
AU  - Vincent,Andrew D
AU  - Passalacqua,Rodolfo
AU  - Buti,Sebastiano
AU  - Amoroso,Domenico
AU  - Camerini,Andrea
AU  - Labianca,Roberto
AU  - Genestreti,Giovenzio
AU  - Boni,Corrado
AU  - Ciuffreda,Libero
AU  - Di Costanzo,Francesco
AU  - de Marinis,Filippo
AU  - Crinò,Lucio
AU  - Santo,Antonio
AU  - Pazzola,Antonio
AU  - Barbieri,Fausto
AU  - Zilembo,Nicoletta
AU  - Colantonio,Ida
AU  - Tibaldi,Carmelo
AU  - Mattioli,Rodolfo
AU  - Cafferata,Mara A
AU  - Camisa,Roberta
AU  - Smit,Egbert F
TI  - Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial
SN  - 1527-7755
PY  - 2013///0507
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carboplatin
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Female
KW  - Glutamates
KW  - Guanine
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Pemetrexed
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2012.43.6758
ER  -